Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Companion Animal Pharmaceuticals Market In 2029?

The market size of companion animal pharmaceuticals has shown substantial growth in the past few years. Expert predictions suggest an increase from $16.49 billion in 2024 to $17.85 billion in 2025, which represents a compound annual growth rate (CAGR) of 8.2%. This historical growth is owed to various factors such as humanization of pets, commitment to preventive healthcare, increased pet insurance coverage, evolving lifestyles, urbanization, worries about zoonotic diseases, and easier access to veterinary healthcare.

The market size of companion animal pharmaceuticals is predicted to experience swift expansion in the coming years, with a projection to reach $26.34 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.2%. The anticipated growth during the forecast period can be traced back to factors such as tailoring medications for pets, the emergence of telehealth and remote veterinary services, emphasis on nutrition and nutraceuticals, ‘one health’ initiatives, and the widening scope of veterinary diagnostic services. The key trends expected during this period encompass advancements in the field of veterinary medicine, specific therapeutics for aging pets, adherence to regulatory norms and safety measures, as well as collaborations and partnerships.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7983&type=smp

Which Factors and External Forces Are Driving Demand in the Companion Animal Pharmaceuticals Market?

The escalating occurrence of zoonotic diseases is projected to fuel the expansion of the companion animal pharmaceuticals market in the future. Zoonotic diseases are those which can naturally transfer from vertebrate animals to humans and vice versa. In response to these illnesses, the pharmaceutical sector is adopting innovative methods and strategies aligned with a unified health approach to fight zoonotic diseases and minimize the chances of transmission. In December 2022, the European Centre for Disease Prevention and Control, a government agency based in Sweden, reported that Campylobacteriosis continues to be the most common zoonosis, with a significant increase in reported cases to 127,840 in 2022. The majority of reported Campylobacteriosis cases were linked to the consumption of chicken and turkey meat. Salmonella, the next most frequent zoonosis, infected 60,050 individuals. After Campylobacteriosis and Salmonellosis, Yersiniosis (6,789 cases), Shigatoxin-producing E. coli infections (6,084 cases), and Listeriosis (2,183 cases) were the most reported zoonotic diseases. Hence, the escalating occurrence of zoonotic diseases is propelling the expansion of the companion animal pharmaceuticals market.

Which Segments in the Companion Animal Pharmaceuticals Offer the Most Growth?

The companion animal pharmaceuticals market covered in this report is segmented –

1) By Animal Type: Dogs, Cats, Horses, Other Companion Animals

2) By Indication: Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications

3) By Distribution Channels: Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies

Subsegments:

1)By Dogs: Vaccines, Antiparasitic, Anti-Inflammatory Drugs

2) By Cats: Vaccines, Antiparasitic, Anti-Inflammatory Drugs

3) By Horses: Vaccines, Antiparasitic, Anti-Inflammatory Drugs

4) By Other Companion Animals: Vaccines, Antiparasitic, Other Therapeutics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7983&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Companion Animal Pharmaceuticals Market?# Market?

North America was the largest region in the companion animal pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theCompanion Animal Pharmaceuticals Market’s Growth?

Adopting advanced data technologies is an emerging trend in the companion animal pharmaceuticals market. Leading companies in this market are concentrated on devising new tech-oriented solutions to fortify their status. For example, in April 2022, Elanco Animal Health Incorporated and Ginkgo Bioworks, both US-based and active in the companion animal pharmaceuticals market, initiated BiomEdit. This is a microbiome innovation company designed to foster advancement in animal health. It will introduce distinctive probiotics and additional animal pharmaceuticals to facilitate novel concepts such as medicated food ingredients, nutritional health, treatments for livestock, and pets, plus biosecurity technologies for tracking animal diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

What Are the Key Elements That Define the Companion Animal Pharmaceuticals Market?

Companion animal pharmaceuticals refer to the pharmaceutical medication process in which animal pharmacists insist on medications, fill prescriptions, and manage drug therapies for animals. It is used in the diagnosis, mitigation, and treatment of different animal diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7983

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model